Spoken Alpha
GLMD
Galmed Pharmaceuticals Ltd.
Overview
Galmed Pharmaceuticals Ltd is a Healthcare company operating in Biotechnology with a $4.9M market cap.
Most recent earnings call: Q4 FY21 on May 2, 2022.
4 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GLMD.
$ curl https://api.spokenalpha.com/v1/companies/GLMDFAQ
Frequently asked about GLMD
Where can I find Galmed Pharmaceuticals Ltd.'s (GLMD) earnings call transcripts?
Spoken Alpha indexes GLMD's earnings call transcripts at https://spokenalpha.com/companies/GLMD. Each call links to attributed speakers and parsed analyst Q&A.
When was Galmed Pharmaceuticals Ltd.'s most recent earnings call?
Galmed Pharmaceuticals Ltd. (GLMD) held its most recent earnings call on 2022-05-02, covering fiscal Q4 2021.
What sector is GLMD in?
Galmed Pharmaceuticals Ltd. (GLMD) operates in the Healthcare sector (Biotechnology industry).